Telix Pharmaceuticals Limited (TLPPF)
USD 16.5
(-0.65%)
USD 16.5
(-0.65%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 0.02 AUD | 104.79% |
| 2022 | -0.34 AUD | -17.24% |
| 2021 | -0.29 AUD | -70.59% |
| 2020 | -0.17 AUD | -41.67% |
| 2019 | -0.12 AUD | -75.44% |
| 2018 | -0.07 AUD | -37.35% |
| 2017 | -0.05 AUD | -4880.0% |
| 2016 | -0.00 AUD | 0.0% |
| 2015 | - AUD | 0.0% |
| 2000 | -0.01 AUD | -72.0% |
| 1999 | -0.01 AUD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.06 AUD | -39.97% |
| 2024 Q2 | 0.04 AUD | -3.59% |
| 2023 FY | - AUD | 104.79% |
| 2023 Q3 | 0.03 AUD | 165.63% |
| 2023 Q2 | -0.05 AUD | -68.28% |
| 2023 Q4 | 0.06 AUD | 103.72% |
| 2023 Q1 | -0.03 AUD | 73.2% |
| 2022 Q3 | -0.05 AUD | 77.04% |
| 2022 Q4 | -0.10 AUD | -89.39% |
| 2022 FY | - AUD | -17.24% |
| 2022 Q1 | -0.12 AUD | 29.41% |
| 2022 Q2 | -0.23 AUD | -91.67% |
| 2021 Q4 | -0.17 AUD | -100.47% |
| 2021 Q3 | -0.08 AUD | 29.33% |
| 2021 FY | - AUD | -70.59% |
| 2021 Q2 | -0.12 AUD | -107.61% |
| 2021 Q1 | -0.06 AUD | 42.2% |
| 2020 Q3 | -0.05 AUD | 28.12% |
| 2020 FY | - AUD | -41.67% |
| 2020 Q4 | -0.10 AUD | -92.68% |
| 2020 Q2 | -0.07 AUD | -102.81% |
| 2020 Q1 | -0.04 AUD | 50.49% |
| 2019 Q3 | -0.04 AUD | 25.89% |
| 2019 FY | - AUD | -75.44% |
| 2019 Q4 | -0.07 AUD | -104.26% |
| 2019 Q1 | -0.02 AUD | -13.88% |
| 2019 Q2 | -0.05 AUD | -99.58% |
| 2018 Q3 | -0.02 AUD | -59.54% |
| 2018 Q4 | -0.02 AUD | 0.0% |
| 2018 FY | - AUD | -37.35% |
| 2018 Q1 | -0.01 AUD | -37.89% |
| 2018 Q2 | -0.01 AUD | 0.0% |
| 2017 FY | - AUD | -4880.0% |
| 2017 Q4 | -0.01 AUD | 0.0% |
| 2017 Q3 | -0.01 AUD | 97.03% |
| 2017 Q1 | -0.32 AUD | 0.0% |
| 2017 Q2 | -0.32 AUD | 0.0% |
| 2016 FY | - AUD | 0.0% |
| 2015 FY | - AUD | 0.0% |
| 2000 FY | - AUD | -72.0% |
| 1999 FY | - AUD | 0.0% |